E-Mail
IMAGE: Time series graph showing daily hospital admissions from sample hospitals in England for patients with heart attack and acute heart failure. The graph also shows key dates in the COVID-19. view more
Credit: University of Leeds
Data analysis is revealing a second sharp drop in the number of people admitted to hospital in England with acute heart failure or a heart attack.
The decline began in October as the numbers of COVID-19 infections began to surge ahead of the second lockdown, which came into force in early November.
The findings, from a research group led by the University of Leeds, have been revealed in a letter to the
E-Mail
IMAGE: Professor Sheena Radford FRS, Director of the Astbury Centre for Structural Molecular Biology, University of Leeds view more
Credit: University of Leeds
The UK s leading scientific academy - the Royal Society - has awarded one of its most prestigious research professorships to an academic at the University of Leeds, to develop new ways of seeing the unseen - the way that proteins interact to shape or to destroy memories.
The award will allow Professor Sheena Radford FRS, Director of the Astbury Centre for Structural Molecular Biology at Leeds, to focus on one of the big unanswered questions in biology - the role that a protein structure called amyloid plays in both building memories that can last for decades, but also in the devastating memory loss experienced by people with neurodegenerative diseases.
E-Mail
IMAGE: Capsid protein pentamers (subunits colour-coded) being recruited to the growing protein shell (brown) during virion assembly by formation of sequence-specific contacts between the genome (packaging signals shown as orange space-filled. view more
Credit: University of Leeds
Researchers have for the first time identified the way viruses like the poliovirus and the common cold virus package up their genetic code, allowing them to infect cells.
The findings, published today (Friday, 8 January) in the journal
PLOS Pathogens by a team from the Universities of Leeds and York, open up the possibility that drugs or anti-viral agents can be developed that would stop such infections.
Credit: Stevepb/pixabay
Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a unique UK trial.
The early stage colorectal, breast or gynecological cancer patients took part in the trial of the eRAPID system, developed by the University of Leeds, which allowed them to report online symptoms from home and receive instant advice on whether to self-manage or seek medical attention.
Patients reported better symptom control and physical wellbeing in the early weeks of treatment, with the system preventing symptom deterioration in about 9% of patients after 12 weeks. Patients reported more confidence in managing their health at the end of their four-month trial period.